收稿日期: 2024-10-10
网络出版日期: 2025-02-28
基金资助
海南省卫生健康委员会科研项目(21A200102);湖南省卫生健康委科研计划项目(202207022525);湖南省自然科学基金项目(2023JJ30770)
Correlation between morphological indexes such as changes of vascular density in deep and shallow layers, retinal hyperreflexia and the response to treatment of macular edema with glucose net
Received date: 2024-10-10
Online published: 2025-02-28
目的 评估深浅层血管密度变化、视网膜高反射点等形态学指标与糖网黄斑水肿(DME)治疗反应的相关性。 方法 回顾性选取2020年4月至2023年11月就诊于眼科的DME患者(45例 59眼)。对比患者治疗前后深浅层血管密度变化、视网膜高反射点等指标变化。使用Pearson检验分析各指标与DME抗血管内皮生长因子(VEGF)治疗反应不佳的相关性。采用受试者工作特征曲线(ROC)分析基线视网膜深层毛细血管丛(DCP)、黄斑中心视网膜厚度(CMT)、视网膜高反射灶(HRF)数量及血流密度(FD300-VD)在诊断DME对抗VEGF治疗反应不佳的价值。 结果 与治疗前相比,治疗后患者的视网膜浅层毛细血管丛(SCP)、DCP、FD300-VD、深浅层血流比(DSFR)上升,CMT厚度明显降低(P < 0.05)。Pearson相关性检验显示,抗VEGF治疗反应不佳患者结局与基线SCP-VD、DCP-VD、DSFR、FD300-VD呈负相关(r = -0.458、-0.433、-0.604、-0.452,P < 0.05),与CMT呈正相关(r = 0.427,P < 0.05)。多因素logistic回归分析结果显示,SCP、DCP、FD300-VD、DSFR上升,CMT降低是影响DME抗VEGF治疗应答的相关因素(OR= 0.285、0.272、0.291、0.268、2.821,P < 0.05)。ROC曲线分析结果显示,基线DCP、CMT、HRF数量、FD300-VD的曲线下面积(AUC)分别为0.918、0.934、0.947、0.927,在诊断DME抗VEGF治疗反应不佳中具有良好的价值。 结论 深浅层血管密度变化、视网膜高反射点等形态学指标在评估DME治疗反应中具有良好的应用价值,可辅助临床治疗工作的开展。
生侠 , 周梦文 , 贺靖凯 , 谢良阔 , 刘骁 . 深浅层血管密度变化和视网膜高反射点评估糖网黄斑水肿治疗反应的效果[J]. 实用医学杂志, 2025 , 41(4) : 575 -579 . DOI: 10.3969/j.issn.1006-5725.2025.04.017
Objective To evaluate the correlation between the changes of vascular density in deep and shallow layers, retinal hyperreflexia and the therapeutic response of diabetic macular edema (DME). Methods Retrospectively selected DME patients (45 cases and 59 eyes) who visited the Department of Ophthalmology from April 2020 to November 2023 as the experimental group. Compare the change of deep and superficial blood vessel density and retinal hyperreflective points before and after treatment of the patients. The correlation between each index and poor response to anti-vascular endothelial growth factor (VEGF) treatment with DME was analyzed using the Pearson test. The value of baseline deep retinal capillary plexus (DCP), central macular retinal thickness (CMT), number of high-reflective foci (HRF) in the retina, and blood flow density (FD300-VD) in diagnosing poor response to anti-VEGF therapy in DME was analyzed using the subject operating characteristic curve (ROC). Results Compared with pre-treatment, patients' superficial retinal capillary plexus (SCP), DCP, FD300-VD, and deep-superficial flow ratio (DSFR) increased and CMT thickness significantly decreased after treatment (P < 0.05). Pearson's correlation test showed that the outcome of patients with poor response to anti-VEGF therapy was negatively correlated with baseline SCP-VD, DCP-VD, DSFR, and FD300-VD (r = -0.458, -0.433, -0.604, and -0.452, P < 0.05) and positively correlated with CMT (r = 0.427, P < 0.05). The results of multifactorial logistic regression analysis showed that a rise in SCP, DCP, FD300-VD, and DSFR, and a decrease in CMT were correlates affecting the response to anti-VEGF therapy in DME (OR = 0.285, 0.272, 0.291, 0.268, 2.821, P < 0.05).The results of ROC curve analysis showed that the AUCs of baseline DCP, CMT, HRF quantity, and FD300-VD were 0.918, 0.934, 0.947, and 0.927, respectively, which were of good value in diagnosing poor response to anti-VEGF therapy in DME. Conclusion Morphologic indicators such as changes in the density of deep and superficial blood vessels and retinal hyperreflective spots have good application value in assessing the response to DME treatment and can assist in clinical treatment.
| 1 | 鲁可,陈小燕. 体质量管理在糖尿病防治中的利与弊[J]. 实用医学杂志, 2024, 40(16): 2219-2223. |
| 2 | 王文娟,齐鸣瑞,田利民.Nrf2在糖尿病心肌病中的作用及中药干预研究进展[J].中国临床药理学与治疗学,2022,27 (10):1163-1170. |
| 3 | SOROUR O A, LEVINE E S, BAUMAL C R, et al. Persistent diabetic macular edema: Definition, incidence, biomarkers, and treatment methods[J]. Surv Ophthalmol, 2023, 68(2): 147-174. doi:10.1016/j.survophthal.2022.11.008 |
| 4 | PRINCE J, KUMAR D, GHOSH A, et al. Surgical management of diabetic macular edema[J]. Curr Diab Rep, 2023, 23(6): 119-125. doi:10.1007/s11892-023-01505-3 |
| 5 | 卢富琨, 马丁, 马昌军. 2型糖尿病视网膜病变患者血清血管内皮生长因子、血管生成素及其受体Tie-2水平及临床意义[J]. 广西医学, 2021, 43(1): 35-39. |
| 6 | 李海东, 方伟, 吴素兰. 非增生期糖尿病视网膜病变患者黄斑区血流密度变化:基于OCTA的定量分析[J]. 眼科新进展, 2021, 41(2): 170-173. |
| 7 | DOUGLAS V P, DOUGLAS K A A, TORUN N. Optical coherence tomography angiography in neuro-ophthalmology[J]. Curr Opin Ophthalmol, 2023, 34(4): 354-360. doi:10.1097/icu.0000000000000955 |
| 8 | MOHAMMADI S, GOURAVANI M, SALEHI M A, et al. Optical coherence tomography angiography measurements in multiple sclerosis: A systematic review and meta-analysis[J]. J Neuroinflammation, 2023, 20(1): 85. doi:10.1186/s12974-023-02763-4 |
| 9 | 中华医学会糖尿病学分会视网膜病变学组. 糖尿病视网膜病变防治专家共识[J]. 中华糖尿病杂志, 2018, 10(4): 241-247. |
| 10 | TAKAMURA Y, YAMADA Y, MORIOKA M, et al. Turnover of microaneurysms after intravitreal injections of faricimab for diabetic macular edema[J]. Invest Ophthalmol Vis Sci, 2023, 64(13): 31. doi:10.1167/iovs.64.13.31 |
| 11 | LECLERCQ M, ANDRILLON A, MAALOUF G, et al. Anti-tumor necrosis factor α versus tocilizumab in the treatment of refractory uveitic macular edema: A multicenter study from the french uveitis network[J]. Ophthalmology, 2022, 129(5): 520-529. doi:10.1016/j.ophtha.2022.02.019 |
| 12 | CEHOFSKI L J, KOJIMA K, KUSADA N, et al. Macular edema in central retinal vein occlusion correlates with aqueous fibrinogen alpha chain[J]. Invest Ophthalmol Vis Sci, 2023, 64(2): 23. doi:10.1167/iovs.64.2.23 |
| 13 | SUN Z, YANG D, TANG Z, et al. Optical coherence tomography angiography in diabetic retinopathy: An updated review[J]. Eye (Lond),2021, 35(1): 149-161. doi:10.1038/s41433-020-01233-y |
| 14 | BORRELLI E, SACCONI R, QUERQUES G, et al. Optical coherence tomography angiography in the management of diabetic retinopathy[J]. Indian J Ophthalmol, 2021, 69(11): 3009-3014. doi:10.4103/ijo.ijo_1367_21 |
| 15 | KILANI A, WERNER J U, LANG G K, et al. Optical coherence tomography angiography findings in proliferative diabetic retinopathy[J]. Ophthalmologica, 2021, 244(3): 258-264. doi:10.1159/000516525 |
| 16 | RABINA G, HILELY A, BAREQUET D, et al. Epiretinal membrane in patients with diabetic macular edema[J]. Ophthalmologica, 2022, 245(5): 446-454. doi:10.1159/000524742 |
| 17 | TEMEL E, BATIO?LU F. Optical coherence tomography angiography findings of diabetic patients with and without retinopathy[J]. Eur J Ophthalmol, 2021, 31(6): 3124-3132. doi:10.1177/1120672121990562 |
| 18 | PANOZZO G, STAURENGHI G, DALLA MURA G, et al. Prevalence of diabetes and diabetic macular edema in patients undergoing senile cataract surgery in Italy: The DIabetes and CATaract study[J]. Eur J Ophthalmol, 2020, 30(2): 315-320. doi:10.1177/1120672119830578 |
| 19 | TAO T, HE D, PENG X, et al. Successful remission with upadacitinib in two patients with anti-tnf-refractory macular edema associated with beh?et's uveitis[J]. Ocul Immunol Inflamm, 2024, 32(8): 1897-1900. doi:10.1080/09273948.2023.2263557 |
| 20 | 许厚银, 郎胜坤. OCTA对糖尿病视网膜病变患者视网膜微血管检测[J]. 国际眼科杂志, 2022, 22(2): 327-330. |
| 21 | WANG M, GARG I, MILLER J B. Wide field swept source optical coherence tomography angiography for the evaluation of proliferative diabetic retinopathy and associated lesions: A review[J]. Semin Ophthalmol, 2021, 36(4): 162-167. doi:10.1080/08820538.2021.1887901 |
| 22 | 卢尚哲, 肖泽锋. 颈动脉内膜中层厚度对2型糖尿病患者黄斑区视网膜微循环的影响:基于OCTA观察[J]. 眼科新进展, 2021, 41(11): 1067-1071. |
| 23 | AGRA C L D M, LIRA R P C, PINHEIRO F G, et al. Optical coherence tomography angiography: Microvascular alterations in diabetic eyes without diabetic retinopathy[J]. Arq Bras Oftalmol, 2021, 84(2): 149-157. doi:10.5935/0004-2749.20210023 |
/
| 〈 |
|
〉 |